Mangoceuticals Share Price Today
(NASDAQ: MGRX)

Name: Mangoceuticals Share Price Today (NASDAQ: MGRX) - Mangoceuticals Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Mangoceuticals share price is $2.57 & ₹219.65 as on 18 Apr 2025, 2.30 'hrs' IST

$2.57

▲

0.47

(22.38%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Mangoceuticals share price in Dollar and Rupees. Guide to invest in Mangoceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mangoceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Mangoceuticals share price movements

Today's Low: $2.12
Today's High: $2.57
$2.57
17.51%
Downside
Day's Volatility :17.59%
Upside
0.1%
52 Weeks Low: $1.49
52 Weeks High: $16.80
$2.57
42.22%
Downside
52 Weeks Volatility :91.16%
Upside
84.7%

Mangoceuticals (MGRX) Returns

Period	Mangoceuticals Inc	Index (Russel 2000)
3 Months	-6.2%	0.0%
6 Months	5.76%	0.0%
1 Year	-41.72%	0.0%
3 Years	-95.72%	-12.9%

Mangoceuticals (MGRX) Key Statistics

in dollars & INR

Previous Close	$2.1
Open	$2.12
Today's High	$2.5725
Today's Low	$2.12
Market Capitalization	$13.3M
Today's Volume	$129.7K
52 Week High	$16.8
52 Week Low	$1.485
Revenue TTM	$615.9K
EBITDA	$-7.5M
Earnings Per Share (EPS)	$-4.84
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-118.31%

How to invest in Mangoceuticals Stock (MGRX) from India?

It is very easy for Indian residents to invest directly in Mangoceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mangoceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mangoceuticals or MGRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mangoceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mangoceuticals shares which would translate to 0.333 fractional shares of Mangoceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mangoceuticals, in just a few clicks!

Returns in Mangoceuticals (MGRX) for Indian investors in Rupees

The Mangoceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Mangoceuticals investment value today

Current value as on today

₹60,618

Returns

₹39,382

(-39.38%)

Returns from Mangoceuticals Stock

₹41,723 (-41.72%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Mangoceuticals (MGRX)

14%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Mangoceuticals Stock from India on INDmoney has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Mangoceuticals

Rating

Trend

Insights on Mangoceuticals Stock (Ticker Symbol: MGRX)

Price Movement
In the last 7 days, MGRX stock has moved up by 34.2%
MGRX vs DOCS (1 yr)
In the last 1 year, Doximity, Inc. has given 114.3% return, outperforming this stock by 166.7%
Price to Sales
ForMGRX every $1 of sales, investors are willing to pay $8.3, whereas for Doximity, Inc., the investors are paying $18.0 for every $1 of sales.

Mangoceuticals Technicals Summary

Sell

Neutral

Buy

Mangoceuticals is currently in a neutral trading position according to technical analysis indicators.

Mangoceuticals (MGRX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Mangoceuticals Inc	-51.72%	5.76%	-41.72%	-95.72%	-95.72%
Tempus Ai	-15.8%	-16.91%	0.5%	0.5%	0.5%
Doximity, Inc.	-15.23%	26.84%	116.04%	10.88%	0.4%
Ge Healthcare Technologies Inc.	-23.76%	-30.55%	-26.18%	3.11%	3.11%
Veeva Systems Inc.	-8.44%	-2.68%	8.86%	16.11%	17.11%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Mangoceuticals Inc	NA	NA	NA	0.0	-1.18	-0.63	NA	4.3
Tempus Ai	NA	NA	NA	-1.71	0.0	-0.59	NA	0.35
Doximity, Inc.	52.78	52.78	2.85	1.31	0.21	0.13	NA	5.5
Ge Healthcare Technologies Inc.	14.17	14.17	1.61	4.68	0.26	0.06	0.0	18.48
Veeva Systems Inc.	49.99	49.99	1.14	6.45	0.14	0.07	NA	35.87

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Mangoceuticals Inc	NA	$13.3M	-95.72%	NA	0.0%
Tempus Ai	NA	$9.0B	0.5%	NA	-116.06%
Doximity, Inc.	Hold	$10.0B	0.4%	52.78	36.6%
Ge Healthcare Technologies Inc.	Buy	$28.1B	3.11%	14.17	10.13%
Veeva Systems Inc.	Buy	$35.9B	17.11%	49.99	26.0%

About Mangoceuticals

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. The company also offers oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand name; and provision of access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. It markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Organization	Mangoceuticals
Employees	3
CEO	Mr. Jacob D. Cohen
Industry	Miscellaneous

Management People of Mangoceuticals

Name	Title
Mr. Jacob D. Cohen	Co-Founder, CEO & Chairman
Mr. Eugene M. Johnston	Chief Financial Officer
Ms. Amanda Elizabeth Hammer	Chief Operating Officer
Mr. Antonios Isaac	President & Director

Important FAQs about investing in MGRX Stock from India :

What is Mangoceuticals share price today?

Mangoceuticals share price today stands at $2.57, Open: $2.12 ; Previous Close: $2.10 ; High: $2.57 ; Low: $2.12 ; 52 Week High: $16.80 ; 52 Week Low: $1.49.

The stock opens at $2.12, after a previous close of $2.10. The stock reached a daily high of $2.57 and a low of $2.12, with a 52-week high of $16.80 and a 52-week low of $1.49.

Can Indians buy Mangoceuticals shares?

Yes, Indians can invest in the Mangoceuticals (MGRX) from India.

With INDmoney, you can buy Mangoceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Mangoceuticals at zero transaction cost.

How can I buy Mangoceuticals shares from India?

It is very easy to buy Mangoceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mangoceuticals (MGRX) be purchased?

Yes, you can buy fractional shares of Mangoceuticals with INDmoney app.

What are the documents required to start investing in Mangoceuticals stocks?

To start investing in Mangoceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.